Scleroderma renal crisis: patient characteristics and long-term outcomes.
about
My approach to the treatment of sclerodermaPrevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisSystemic sclerosis: commonly asked questions by rheumatologistsRenal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and managementA rare presentation of micro-angiopathic haemolytic anaemia in a critically ill patient: a case reportScleroderma renal crisis or thrombotic thrombocytopenic purpura: seeing through the masquerade.Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndromeDelayed onset of posterior reversible encephalopathy syndrome in a case of scleroderma renal crisis with maintenance hemodialysis: Case report and literature review.Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibitionMistaken identity: normotensive scleroderma renal crisis.Kidney dysfunction in patients with pulmonary arterial hypertensionCorticosteroids and the risk of scleroderma renal crisis: a systematic review.Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.Spontaneous subdural haemorrhage in a patient with scleroderma renal crisisAn International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcomes-Methodology and Preliminary Results.Scleroderma renal crisis: a pathology perspectiveCardiac manifestations in systemic sclerosis.Are There Clinical Differences in Limited Systemic Sclerosis according to Extension of Skin Involvement?HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.Mortality in systemic sclerosis-a single centre study from the UK.Renal involvement in autoimmune connective tissue diseases.Vascular involvement in systemic sclerosis (scleroderma).Is thrombotic microangiopathy a paraneoplastic phenomenon? Case report and review of the literature.Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsyThe current state of biomarkers in systemic sclerosisHypertensive emergencies: a new clinical approach.Scleroderma renal crisis in tropical region: two senegalese cases.A case report of malignant hypertension in a young womanCD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosisOxalate nephropathy in systemic sclerosis: Case series and review of the literature.A prediction model for progressive disease in systemic sclerosisProteinuria in systemic sclerosis: reversal by ACE inhibitionRenal manifestations of systemic sclerosis--clinical features and outcome assessment.Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.Diagnosis and classification of systemic sclerosis.Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
P2860
Q24618843-0A4FBED1-00B4-4549-A601-772A6CA697B0Q27000819-4D46821B-C243-47BA-82FB-F4F354AB9CE0Q27021067-2EEEFB18-6912-420A-AD5C-40D7939CD261Q27023769-ABA5E67D-83AA-4C31-9DF9-60FC2E990A74Q28751694-43DF357E-CBC1-494A-8257-F4F6C52A64A2Q33423227-51BAE883-A7D0-4885-B8BD-0CB84DAF96EAQ33427917-B706C41E-4D51-4D40-AC19-EE12A1C89333Q33437964-83E7C09B-DA70-4A64-92DB-4E97F6622DBEQ33628275-1CA0D31F-E09D-476F-A633-809A2FC99B94Q33691380-7B228955-7824-4CC1-877F-C00B8D30212AQ33738621-87039E0A-AA49-4249-8223-E46BAB5AAB59Q33763415-C1E0C113-402B-4C0A-AC46-ABEAD6EE04C0Q34106037-5EE06093-EC1D-48A7-AE12-6352DE4D7081Q34107962-681215BE-81DF-40C8-8030-051EED972339Q34151741-D8BA55FF-65FF-4B1B-9D18-8DB3C124626AQ34165117-581EA28F-FC87-4BFF-861E-689EEF3394DDQ34218928-3DC97D10-7387-4E13-8C4D-78912359CA52Q34251904-05EB240D-3560-46EF-A9BF-5B46AD10FA16Q34567867-B9DF64AB-8326-42A8-867A-939B26145E97Q34625202-01179F97-D17B-4F08-AA1B-00E3AF545533Q34653727-DBFD184C-E05C-49CB-B639-9971AF681CCFQ34654954-5A0FAA6D-B471-4EBB-9F91-F5F280BECA93Q35557424-D8AAFF07-E0B0-4789-9EE0-6ADFA2502E31Q35574600-C1FF8D78-99FC-4840-BC0F-E5FE6EE3AAF5Q35597574-E1A7776F-532E-44C7-8821-7B28EC9F167EQ35896754-37D5035D-9136-4E29-9538-63E494DBB09AQ35928181-01AAA400-AD47-4255-8517-D56DD355720CQ36042866-6B3D15C9-0FC2-44A3-9E64-7BAD8B0244DCQ36070531-00EB9EEC-174C-45E7-AF3A-632361AD062FQ36106506-61779C33-3919-430A-85D0-EAB130761FCFQ36307532-CF2D01D0-8FA0-4BEF-8536-35866595DD28Q36375900-FEFAE564-55B4-4AA2-B97F-71D318E1DF43Q37115067-CDC39426-7D5F-4B86-99E7-1DE3BDC3BB1EQ37265862-2300A801-EDC5-4A96-B73E-D7E1A7A06B37Q37280014-9EE6D6A5-8957-4723-86CB-1531A764EEFFQ37310583-A9EB10D7-FAC1-4A4F-964E-7B648430F832Q37423983-7295A0A7-E969-4E71-80FA-575281CD6C03Q37655603-CFE2C406-402B-4D40-B8F1-98CCA67F4D6AQ37689570-629CD168-6F83-4D50-80E1-7166233EABE1Q37690735-CF471745-3FEF-483A-9554-D02250832D87
P2860
Scleroderma renal crisis: patient characteristics and long-term outcomes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@ast
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@en
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@nl
type
label
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@ast
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@en
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@nl
prefLabel
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@ast
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@en
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@nl
P2093
P356
P1476
Scleroderma renal crisis: patient characteristics and long-term outcomes.
@en
P2093
Kingdon EJ
Stratton RJ
P304
P356
10.1093/QJMED/HCM052
P407
P577
2007-06-29T00:00:00Z